🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A remaining hurdle for long-read sequencing is scalability and cost. Here, we developed a single flowcell ONT protocol + push-button pipeline that generates state-of-the-art small and structural variant calls and scales to 1000s of genomes: biorxiv.org/content/10.110…

🧵[1/2] Build your profile at the intersection of #neurodegenerative and #psychiatric research! #GBD23   Strengthen understanding of #BrainDisease genetics, by sharing insights from these interconnected areas of #neuroscience.    Abstract D/L 21 March➡️bit.ly/3WrybS3

New paper from Elisangela Bressan Cornelis Blauwendraat & FOUNDIN-PD program colleagues presents a multi-layered molecular dataset from analysis of differentiated iPSCs to dopamine neurons from 95 PPMI participants with varying #Parkinsons genetic variants cell.com/cell-genomics/…

Thinking about changing careers to #DataScience? Apply for the NIH #fellowship through CARD to get a paid master’s degree from UMBC and get experience working with real data! Apply by May 1, 2023: tinyurl.com/3xssv6c9 #CARDMastersProgram

🧵[1/2] Last chance to submit your abstract for #GBD23! Share your insights on #neuro disease #pathophysiology, developed through the application of innovative #genomic approaches and tools. 📊 ⏰Submit by 21 March: bit.ly/3WrybS3 #BrainDisorders

Interested in hearing about this research in more detail? Check out this webinar with Kimberley Billingsley and Pilar Alvarez Jerez, on 26th April. Register here: technologynetworks.com/tn/webinars/sc… 5/n

🧵New updated wet-lab protocols for scalable Oxford Nanopore sequencing with LSK114/R.10, active through our NIH-CARD protocols.io workspace - Frontal cortex 🧠: dx.doi.org/10.17504/proto…

What an awesome meeting! Thank you all! #GP2AIM2023

(1/2) Thanks to PBS News for giving me the opportunity to chat with John Yang about the groundbreaking #GBA1discovery from Aligning Science Across Parkinson’s's #GP2 researchers! Intentional #collaboration + #inclusive research paves the way for #discoveries 🙌🏾🙌🏾 We're moving full speed ahead!

Congrats Andrew for this more than deserved award!!

🏆 Exciting news from #MDSCongress, GP2 Lead, Andrew Singleton just gave the C. David Marsden Award Lecture. This award recognizes the contributions of outstanding scholars and inspiring neuroscientists to the field of Movement Disorders. Congratulations Andrew 🎉

Halfway through MDS #MDSCongress! GP2 representatives are loving the opportunity to meet with attendees. Stop by table 16 and say hi! 👋

Congratulations to Thomas Gasser, Ellen Sidransky and Andrew Singleton, who win the 2024 Breakthrough Prize in Life Sciences for discovering key genetic risk factors for Parkinson's disease. breakthroughprize.org/News/83 The National Institute on Aging (NIA) NIH National Human Genome Research Institute @DZNE_en Universität Tübingen

Our CARD pilot paper with Kimberley Billingsley Cornelis Blauwendraat @BenedictPaten and many others is online! We establish a wet + dry lab protocol for single nanopore flow cell sequencing, which generates state-of-the-art SNP and SV calls + assemblies. rdcu.be/dl901

First LARGE-PD meeting in the books! It was an in redoble experience , all thanks to this amazing group of people who are compromised with improving things for people with Parkinson’s in Latinoamérica! Proud to be part of this effort! Thank you Cali 🇨🇴

🌟I’m so excited to announce the Marsan lab at #NIH #NIA #CARD is opening its doors! I'm seeking dedicated #Postdocs to join our mission in #ADRD research using omics and organoids 🧠. Join us in this groundbreaking work at the forefront of science. Apply today! Please RT

Long time in the works, new multi-ancestry Parkinson's meta-GWAS. 12 potential novel risk loci, some analyses of heterogeneity across populations and fine-mapping for 6 known loci. Shout outs to all the collaborators! rdcu.be/duEF1 <- open access

Preprint out now! Excited to announce that our manuscript titled "African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1" can now be found here medrxiv.org/content/10.110… .

Happy to share our work on a-syn SAA positivity rates in PSP (8%) + CBS (24%). We discuss how this may be due to Lewy body co-pathology which impacts on clinical course in PSP. Thanks to patients, investigators + funders The PSP Association CBD Solutions NIH medrxiv.org/content/10.110…

We are excited to share a longitudinal association study of CSF α-Synuclein Seed Amplification Assay Positivity with Alzheimer's disease progression and cognitive decline. Cornelis Blauwendraat Amprion The pre-print is available here: medrxiv.org/content/10.110…